business
Guardian Pharmacy Services Q1 Earnings Call Highlights
Key takeaways
- Guardian Pharmacy Services Q1 Earnings Call Highlights Market Beat Mon, May 11, 2026 at 12:14 AM GMT+7 7 min read GRDN Guardian Pharmacy Services logo Key Points Interested in Guardian Pharmacy Services, Inc.?
- Management said the IRA transition has largely matched expectations and raised full-year adjusted EBITDA guidance to $123 million-$127 million while keeping revenue guidance unchanged at $1.4 billion-$1.42 billion;
- 5 Small-Cap Stocks With Impressive Growth and Upside Potential
Guardian Pharmacy Services Q1 Earnings Call Highlights Market Beat Mon, May 11, 2026 at 12:14 AM GMT+7 7 min read GRDN Guardian Pharmacy Services logo Key Points Interested in Guardian Pharmacy Services, Inc.? Here are five stocks we like better.
Guardian Pharmacy Services said it had a solid Q1 2026 despite the Inflation Reduction Act’s drug pricing pressure, reporting revenue of $336.6 million, up 2% year over year, and double-digit growth in residents and script volumes.
The company’s profitability improved sharply, with gross profit up 19% to $76 million and adjusted EBITDA up 27% to $29.8 million, helped by favorable payer dynamics and a one-time manufacturer inventory credit tied to the IRA.
Article preview — originally published by Yahoo Finance. Full story at the source.
Read full story on Yahoo Finance →
More top stories
Also covered by
Investing.com
Earnings call transcript: Schaeffler AG Q1 2026 beats EPS forecast by 237%
Investing.com
Earnings call transcript: Martinrea’s Q1 2026 earnings miss estimates
Investing.com
Earnings call transcript: IPC’s Q1 2026 results show solid performance
Investing.com
Earnings call transcript: Backblaze Q1 2026 earnings beat boosts stock
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop